The past is prologue: Reconceptualizing methadone and buprenorphine for post-operative pain.

This article examined the potential benefits of using methadone and buprenorphine, medications commonly used to treat opioid use disorder (OUD), for managing post-operative pain. The authors aimed to evaluate their effectiveness compared to traditional opioids, focusing on pain relief, reduced need for additional painkillers, and patient satisfaction.

Opioids are widely used for pain relief after surgery, but their use is linked to significant risks, such as addiction, prolonged use, and overdose. In contemporary practice, methadone and buprenorphine are primarily known as treatments for OUD but were originally developed as painkillers. Employing them for post-operative pain management could offer safer and more effective alternatives, benefiting both patients and healthcare systems by reducing the risks associated with conventional opioids. This work is particularly relevant given the ongoing opioid crisis and the need for improved pain management strategies.

The authors conducted a high-level review of existing clinical studies, including systematic reviews and meta-analyses, which pooled data from numerous trials. These studies evaluated the effects of methadone and buprenorphine on pain relief, opioid consumption, and patient satisfaction in post-operative settings. They also reviewed safety profiles and clinical guidelines for the use of these medications during surgery.

Methadone and buprenorphine were found to provide effective pain relief and reduce the need for additional opioids after surgery. Methadone, administered during surgery, led to lower pain scores and higher patient satisfaction for up to 72 hours post-operatively. Similarly, buprenorphine resulted in lower pain scores and reduced need for rescue pain medication compared to traditional opioids while offering unique safety benefits, such as a lower risk of respiratory depression and reduced abuse potential. Both drugs demonstrated comparable or fewer side effects than standard opioids.

This work did not receive any financial support, including departmental or institutional funding/support. The content is solely the responsibility of the authors and does not necessarily reflect the position or policy of the Department of Veterans Affairs or any of its academic affiliates. Yale University also provided funding and support for this research.